It is also worth mentioning that NKp46 expression was not significantly different in B- (FPKM = 0.69) and T-ALL (FPKM = 0.61) subjects from other types of cancers (FPKM = 0.71) (Figure 1). This evidence concerns the gene NCR1 and acute lymphoblastic leukemia.